Clinical trial

Immunologic Memory (Supp. of ATN 024)

NCT00142753 · University of North Carolina, Chapel Hill, Other · Completed

Key facts

NCT number NCT00142753
Title Immunologic Memory (Supp. of ATN 024)
Official title Correlates of HBV-Specific B Cell Memory Following Vaccination in HIV-Infected Adolescents and HIV-Uninfected Adolescents: A Substudy of ATN 024 and ATN 025
Lead sponsor University of North Carolina, Chapel Hill, Other
Collaborators National Institute on Drug Abuse (NIDA) NIH National Institute of Mental Health (NIMH) National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Status Completed
Phase Phase 4
Study type Interventional
Conditions HIV Infections
Intervention type Biological
Interventions Engerix B, Twinrix for ATN 024, Recombivax, Twinrix for ATN 025
Enrollment 95
Start date Aug 1, 2005
Primary completion Nov 1, 2007
Completion Nov 1, 2007
First posted Sep 2, 2005
Last update posted Feb 28, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies